Service delivery outcomes and participant characteristics according to postpartum long-acting reversible contraceptive choice in Kigali, Rwanda, August 2017–October 2018 (among n=12 068 women who received our intervention and delivered at a study health facility)
| Parameter | PP implant (n=1252) | PPIUD (n=3372) |
| PP LARC promotions | ||
| Promotions received per client (n) (mean, SD)* | 1.1 (0.4) | 1.1 (0.3) |
| Insertions per month (n) (mean, SD) | 83.5 (51.9) | 224.8 (75.3) |
| LARC uptake | 10.4% | 27.9% |
| LARC insertion timing | ||
| Before leaving hospital | 53% | 91% |
| ≤6 weeks PP | 47% | 9% |
| LARC recipients' demographics | ||
| Age (mean, SD) | 27.0 (5.6) | 28.3 (6.0) |
| Parity (mean, SD) | 2.3 (1.3) | 2.4 (1.5) |
| Insertion outcomes | ||
| Women’s self-reported pain during insertion† (mean, SD) | 2.0 (2.6) | 1.8 (1.0) |
| Women’s self-reported anxiety during insertion† (mean, SD) | 2.1 (2.6) | 1.7 (0.9) |
| Provider self-reported ease-of-insertion‡ (mean, SD) | 9.9 (0.7) | 9.2 (1.0) |
Continuous measures were normally distributed.
*Women who had already received a postpartum family planning method were not systematically counselled again (women who had received a method but expressed interest in receiving a different method could receive additional counselling on request but were not included in this calculation).
†Assessed on a 10-point Likert scale where 1=no anxiety/pain and 10=maximum anxiety/pain.
‡Assessed on a 10-point Likert scale where 1=least amount of ease-of-insertion and 10=most ease.
LARC, long-acting reversible contraception; PP, postpartum; PPIUD, postpartum intrauterine device.